Report
EUR 146.34 Purchase single report

Moody's says Zoetis' acquisition of Abaxis is credit negative

Moody's Investors Service commented that Zoetis Inc.'s (Zoetis, Baa1 stable) plans to acquire Abaxis, Inc. (unrated), for $2 billion is credit negative. The acquisition affords Zoetis access to a fast growing area within animal health but will result in an increase in financial leverage. There i...
Underlying
Zoetis

Zoetis engages in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company organizes and operates its business in two segments: the U.S. and International. The company's main product categories are anti-infectives, vaccines, parasiticides, medicated feed additives, and other pharmaceutical products such as allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. The company's other product categories include nutritionals and agribusiness, as well as products and services in complementary areas, including biodevices, diagnostics and genetics.

Provider
Moody's Investors Service
Moody's Investors Service

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

  • 130 countries
    11,000 corporate issuers
    21,000 public finance issuers
    76,000 structured finance obligations



Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.



Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions. 

Other Reports on these Companies
Other Reports from Moody's Investors Service

ResearchPool Subscriptions

Get the most out of your insights

Get in touch